Literature DB >> 28663334

Mitochondrial Genomic Backgrounds Affect Nuclear DNA Methylation and Gene Expression.

Carolyn J Vivian1,2, Amanda E Brinker1,2,3, Stefan Graw4, Devin C Koestler4,5, Christophe Legendre6, Gerald C Gooden6, Bodour Salhia6, Danny R Welch7,2,3,5.   

Abstract

Mitochondrial DNA (mtDNA) mutations and polymorphisms contribute to many complex diseases, including cancer. Using a unique mouse model that contains nDNA from one mouse strain and homoplasmic mitochondrial haplotypes from different mouse strain(s)-designated Mitochondrial Nuclear Exchange (MNX)-we showed that mtDNA could alter mammary tumor metastasis. Because retrograde and anterograde communication exists between the nuclear and mitochondrial genomes, we hypothesized that there are differential mtDNA-driven changes in nuclear (n)DNA expression and DNA methylation. Genome-wide nDNA methylation and gene expression were measured in harvested brain tissue from paired wild-type and MNX mice. Selective differential DNA methylation and gene expression were observed between strains having identical nDNA, but different mtDNA. These observations provide insights into how mtDNA could be altering epigenetic regulation and thereby contribute to the pathogenesis of metastasis. Cancer Res; 77(22); 6202-14. ©2017 AACR. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28663334      PMCID: PMC5690839          DOI: 10.1158/0008-5472.CAN-17-1473

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  64 in total

Review 1.  Epigenetics, epidemiology and mitochondrial DNA diseases.

Authors:  Patrick F Chinnery; Hannah R Elliott; Gavin Hudson; David C Samuels; Caroline L Relton
Journal:  Int J Epidemiol       Date:  2012-01-28       Impact factor: 7.196

Review 2.  Epigenetic modifications and human disease.

Authors:  Anna Portela; Manel Esteller
Journal:  Nat Biotechnol       Date:  2010-10       Impact factor: 54.908

Review 3.  Metabolic control of epigenetics in cancer.

Authors:  Adam Kinnaird; Steven Zhao; Kathryn E Wellen; Evangelos D Michelakis
Journal:  Nat Rev Cancer       Date:  2016-09-16       Impact factor: 60.716

Review 4.  Crosstalk between nuclear and mitochondrial genomes.

Authors:  R O Poyton; J E McEwen
Journal:  Annu Rev Biochem       Date:  1996       Impact factor: 23.643

5.  MethPrimer: designing primers for methylation PCRs.

Authors:  Long-Cheng Li; Rajvir Dahiya
Journal:  Bioinformatics       Date:  2002-11       Impact factor: 6.937

Review 6.  Mitochondria and cell bioenergetics: increasingly recognized components and a possible etiologic cause of Alzheimer's disease.

Authors:  Russell H Swerdlow
Journal:  Antioxid Redox Signal       Date:  2011-09-15       Impact factor: 8.401

Review 7.  Mitochondrial regulation of epigenetics and its role in human diseases.

Authors:  Sheroy Minocherhomji; Trygve O Tollefsbol; Keshav K Singh
Journal:  Epigenetics       Date:  2012-04-01       Impact factor: 4.528

8.  Epigenomic profiling of DNA methylation in paired prostate cancer versus adjacent benign tissue.

Authors:  Milan S Geybels; Shanshan Zhao; Chao-Jen Wong; Marina Bibikova; Brandy Klotzle; Michael Wu; Elaine A Ostrander; Jian-Bing Fan; Ziding Feng; Janet L Stanford
Journal:  Prostate       Date:  2015-09-18       Impact factor: 4.104

9.  Qualitative differences between C57BL/6J and DBA/2J mice in morphine potentiation of brain stimulation reward and intravenous self-administration.

Authors:  Greg I Elmer; Jeanne O Pieper; Lindsey R Hamilton; Roy A Wise
Journal:  Psychopharmacology (Berl)       Date:  2009-12-15       Impact factor: 4.530

10.  Mitochondrial genetic background modulates bioenergetics and susceptibility to acute cardiac volume overload.

Authors:  Jessica L Fetterman; Blake R Zelickson; Larry W Johnson; Douglas R Moellering; David G Westbrook; Melissa Pompilius; Melissa J Sammy; Michelle Johnson; Kimberly J Dunham-Snary; Xuemei Cao; Wayne E Bradley; Jinju Zhang; Chih-Chang Wei; Balu Chacko; Theodore G Schurr; Robert A Kesterson; Louis J Dell'italia; Victor M Darley-Usmar; Danny R Welch; Scott W Ballinger
Journal:  Biochem J       Date:  2013-10-15       Impact factor: 3.857

View more
  26 in total

Review 1.  The unresolved role of mitochondrial DNA in Parkinson's disease: An overview of published studies, their limitations, and future prospects.

Authors:  Amica C Müller-Nedebock; Rebecca R Brennan; Marianne Venter; Ilse S Pienaar; Francois H van der Westhuizen; Joanna L Elson; Owen A Ross; Soraya Bardien
Journal:  Neurochem Int       Date:  2019-06-21       Impact factor: 3.921

2.  The second genome: Effects of the mitochondrial genome on cancer progression.

Authors:  Adam D Scheid; Thomas C Beadnell; Danny R Welch
Journal:  Adv Cancer Res       Date:  2019-02-27       Impact factor: 6.242

Review 3.  Genetic insights into the morass of metastatic heterogeneity.

Authors:  Kent W Hunter; Ruhul Amin; Sarah Deasy; Ngoc-Han Ha; Lalage Wakefield
Journal:  Nat Rev Cancer       Date:  2018-02-09       Impact factor: 60.716

Review 4.  Mitohormesis, UPRmt, and the Complexity of Mitochondrial DNA Landscapes in Cancer.

Authors:  Timothy C Kenny; Maria L Gomez; Doris Germain
Journal:  Cancer Res       Date:  2019-09-04       Impact factor: 12.701

5.  Mitochondrial Haplotype of the Host Stromal Microenvironment Alters Metastasis in a Non-cell Autonomous Manner.

Authors:  Amanda E Brinker; Carolyn J Vivian; Thomas C Beadnell; Devin C Koestler; Shao Thing Teoh; Sophia Y Lunt; Danny R Welch
Journal:  Cancer Res       Date:  2019-12-17       Impact factor: 12.701

Review 6.  Motivation for Launching a Cancer Metastasis Inhibition (CMI) Program.

Authors:  Jill M Pulley; Rebecca N Jerome; Martin L Ogletree; Gordon R Bernard; Robert R Lavieri; Nicole M Zaleski; Charles C Hong; Jana K Shirey-Rice; Carlos L Arteaga; Ingrid A Mayer; Kenneth J Holroyd; Rebecca S Cook
Journal:  Target Oncol       Date:  2018-02       Impact factor: 4.493

Review 7.  Roles of the mitochondrial genetics in cancer metastasis: not to be ignored any longer.

Authors:  Thomas C Beadnell; Adam D Scheid; Carolyn J Vivian; Danny R Welch
Journal:  Cancer Metastasis Rev       Date:  2018-12       Impact factor: 9.264

8.  Mitochondrial polymorphisms contribute to aging phenotypes in MNX mouse models.

Authors:  Carolyn J Vivian; Travis M Hagedorn; Roy A Jensen; Amanda E Brinker; Danny R Welch
Journal:  Cancer Metastasis Rev       Date:  2018-12       Impact factor: 9.264

9.  Mitochondrial Haplotype Alters Mammary Cancer Tumorigenicity and Metastasis in an Oncogenic Driver-Dependent Manner.

Authors:  Amanda E Brinker; Carolyn J Vivian; Devin C Koestler; Trevor T Tsue; Roy A Jensen; Danny R Welch
Journal:  Cancer Res       Date:  2017-10-25       Impact factor: 12.701

10.  Mitochondrial genetics cooperate with nuclear genetics to selectively alter immune cell development/trafficking.

Authors:  T C Beadnell; C Fain; C J Vivian; J C G King; R Hastings; M A Markiewicz; D R Welch
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-12-30       Impact factor: 5.187

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.